A global medical technology company developing innovative implantable mechatronics technology to treat stress urinary incontinence (SUI). Its lead product, UroActive, is a smart automated artificial urinary sphincter implant.
Investment Rounds
Capital activity and funding progression
| Amount | Date | Round |
|---|---|---|
| $60 M | May, 2026 | unspecified |
Industries
Frequently Asked Questions
Where is UroMems located?
UroMems is located in Grenoble, France.
What industries does UroMems operate in?
UroMems operates in the following industries: medical technology, medtech, healthcare.
How much total funding has UroMems raised?
UroMems has raised a total of $60,000,000.
Who are the investors in UroMems?
The investors in UroMems are: Ajax Health Fund I.
What is UroMems?
UroMems is a global medical technology company focused on designing and developing smart active implantable devices to treat stress urinary incontinence.
What is UroActive by UroMems?
UroActive is the company's first smart, automated artificial urinary sphincter. It is designed to be placed around the urethral duct and uses embedded micro-sensors and algorithms to adjust pressure automatically based on a patient's activity, eliminating the need for manual adjustments.
Is the UroMems UroActive device currently available for patients?
No, UroActive has not received marketing authorization from the FDA or in the European Union and is not currently available for sale or general clinical use.
What technology powers the UroMems UroActive implant?
UroActive is powered by a proprietary MyoElectroMechanical System (MEMS), which integrates micro-sensors, embedded control algorithms, and mechatronic actuation to provide dynamic, patient-specific treatment.
How does UroMems aim to improve upon existing incontinence treatments?
UroMems aims to improve patient quality of life by replacing traditional devices that require manual operation with a smart, automated system that is easier to use, less invasive, and better suited to a patient's individual activity levels.